All 54 GLP-1 providers, side-by-side

Pros

• +Same-day physician consults, one of the few platforms offering telehealth appointments the same day you apply
• +80,000+ customer base with a 4.3-star Trustpilot rating (600+ reviews) provides real social proof of reliability
• +100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment

Cons

• −Standard semaglutide pricing is $289/mo, above competitors at $99-199/mo; the TAKEOFF 3-month entry (about $99/mo first month) and annual plans from $99/mo bring the effective rate down
• −$29.99 shipping fee per order where most competitors ship free; factor it into your monthly total
• −A $50 non-refundable cancellation fee applies after intake approval; decide before the consult, and cancel at least 48 hours ahead of your monthly processing date

Pros

• +Success by Sesame program launched 2026, $59/mo on a 3/6/12-month plan, includes labs, unlimited messaging, and provider choice; medication is separate
• +Brand-name cash pricing is competitive, Wegovy pen $199 intro / $349 ongoing, Zepbound vial $299, Wegovy pill $149
• +Foundayo (Lilly's FDA-approved oral GLP-1) available as of April 2026 at $149/mo

Cons

• −Two distinct products (pay-per-visit vs the Success membership) sit side by side, so decide which you're buying before checkout
• −The $59/mo Success by Sesame rate requires a 3-month minimum commitment; month-to-month is available at $99/mo if you don't want to commit
• −Compounded meds are de-emphasized in the current marketing, the platform now leads with FDA-approved brand-name paths

Pros

• +The published $297/mo compounded semaglutide injection tier includes medication, consultations, shipping, and pharmacy fees
• +Format-specific prices are published on the site, which makes the advertised medication and service bundle easier to compare
• +Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval

Cons

• −Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu
• −The $297/mo injectable semaglutide rate sits above Henry Meds ($199) and TrimRx (starting at $179); Direct Meds' own sublingual semaglutide drops at $179 are the budget path if the premium stings
• −BBB shows 248 complaints and roughly 1.1/5 customer-review stars, with recurring reports of unauthorized charges, cancellation difficulty, billing confusion, and unfulfilled or delayed orders

Pros

• +GLP-1 from $49 your first month, then $212/mo, with access to both brand-name and compounded; wafers as low as $84/mo on the 6-month plan
• +Offers combination therapies (GLP-1 + B12, GLP-1 + NAD+) for patients wanting enhanced protocols
• +Quick asynchronous consultations, most patients approved within 24 hours without video calls

Cons

• −Check-ins are patient-initiated rather than scheduled; portal requests are usually answered within 24 hours, but you drive the cadence
• −No insurance billing, and customer support runs business days only, no weekends

Pros

• +Clinical-service-only path to brand Wegovy and Zepbound at $99/mo, prescription goes to patient's pharmacy (you fill separately using insurance or cash)
• +Steep multi-month commitment discounts on compounded sema, $158/mo on 12-month plan ($1,900 upfront) vs $249/mo month-to-month
• +Same price at all dose levels for compounded, no cost escalation as you titrate up

Cons

• −The $99/mo Wegovy/Zepbound tier is the clinical service only. Medication is billed separately at your pharmacy (can be $1,000+/mo cash without insurance). Choose this tier when your insurance covers the drug itself.
• −The best compounded rates require prepayment: $1,050 upfront for 6 months, $1,900 for 12. Start at $249 month-to-month if you want to test fit first.
• −The intake is a 90-second quiz. Fast, but lighter screening than competitors with full medical intakes. Better suited to patients who already know GLP-1 basics.

Pros

• +Industry-leading delivery speed, most patients receive medication within 2-3 days of enrollment
• +$199/mo is competitively priced for an all-inclusive compounded program with good support
• +Streamlined onboarding with no video call, approved and shipped faster than most competitors

Cons

• −The core $199 program is compounded semaglutide and tirzepatide; brand-name access runs through a separate $99/mo pathway subscription with medication billed at pharmacy rates on top
• −Newer company (founded 2024) with limited long-term track record and outcome data; the 4.6/5 Trustpilot rating across 766 reviews is the strongest early evidence available
• −No insurance billing and no FSA/HSA superbills currently available

Pros

• +Two named board-certified doctors (Dr. Michael Wasef MD and Dr. Andrew Sakla DO), most compounded GLP-1 providers don't publicly name their prescribers.
• +4.6 stars across 1,065 verified Trustpilot reviews, 84% give 5 stars. Top complimented theme: customer service.
• +Cheap if you commit: $146/mo for compounded semaglutide on the 6-month plan.

Cons

• −Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro.
• −The $146/mo price requires a 6-month upfront commitment (month-to-month is meaningfully more expensive). The Klarna/Affirm/Afterpay financing exists to spread exactly that upfront cost.
• −No live tele-visit option, only async review. Faster, but less depth if you have a complex health history and want a provider you can talk to.

Pros

• +Oral dissolving tablets exclusively, zero injections for any GLP-1 option
• +Publicly traded on NASDAQ (MGRX), SEC-required financial transparency that private competitors can't match
• +Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment

Cons

• −Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.
• −Early-stage public company with limited revenue; the same SEC filings that provide transparency also show the financial uncertainty reflected in the stock.
• −Oral tablets are the only format, with no injectable option if you want higher bioavailability. If you may switch to injections later, pick a platform that carries both.

Pros

• +$119/mo for compounded semaglutide is among the lowest published entries in our provider table
• +No-subscription model, patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
• +Compounded tirzepatide at $185/mo is competitively priced for a GLP-1+GIP dual agonist

Cons

• −Brand-name pricing ($1,200-$1,500/mo) is significantly above market, NovoCare lists Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and LillyDirect has Zepbound from $299. Use Oak for its compounded tiers and buy brand-name direct
• −No published lab panels and no specialty (obesity medicine) physicians disclosed, clinical oversight is lighter than lab-driven platforms
• −The 'up to 50% cheaper than competitors' marketing claim is unverified and inconsistent, judge Oak on its posted prices, which are genuinely low, not on the slogan

Pros

• +Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats, semaglutide and tirzepatide each in two formats, broader format menu than most compounded-only platforms
• +10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
• +Competitive entry pricing, $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market

Cons

• −Founding year, corporate ownership, and named prescribers are NOT publicly disclosed, and the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients; if disclosed leadership matters to you, weigh this first
• −49 states only, service is unavailable in Louisiana and outside the United States
• −Billing runs on a 28-day recurring cycle and payments are non-refundable once processed, with no proration for partial months; cancel before your next cycle processes to avoid paying for an unused month

Pros

• +Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
• +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
• +Typical insured copay of ~$30/mo for most members, dramatically lower than cash-pay alternatives

Cons

• −Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying
• −The insurance navigation process adds steps compared to simple cash-pay platforms; the payoff is the ~$30 typical copay
• −Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does

Pros

• +Oral tirzepatide gum is rare. Real option for needle-phobic users. (How well it absorbs vs the FDA-approved injection isn't published.)
• +Advertised injection floors of $79 for semaglutide and $129 for GLP-1 + GIP, verified August 14, 2026. The FAQ says the selected rate holds within the chosen plan.
• +Four plan lengths are disclosed (4, 12, 24 and 52 weeks), giving shoppers a shorter-term option as well as longer-plan pricing.

Cons

• −Runs two sibling storefronts most shoppers will never connect to it: SnagRx (snagrx.com) and RodeoMeds (rodeomeds.com) are the same legal entity, Modern Metabolic Medicine, Inc. SnagRx still advertises a separate $69/$119 promotion; Embody now advertises $79/$129 under its own plan menu. Neither site tells shoppers they share an operator. See our [SnagRx review](/reviews/snagrx)
• −The $79/$129 figures are advertised floors tied to a selected 4-, 12-, 24- or 52-week plan, not a verified no-commitment month-to-month rate. Confirm the plan length and total before payment.
• −Trustpilot rating is 3.8 / 5 across 5,305 reviews, verified August 14, 2026. Price and billing remain recurring complaint themes, although many reviews describe earlier pricing structures.

Pros

• +Flat $165/mo at all dose levels, price doesn't increase as you titrate up to maintenance doses
• +100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews, strong social proof
• +Semaglutide + B12 formulation helps reduce nausea, the most common GLP-1 side effect

Cons

• −Available in 42 states, not all 50 (8 states are excluded). Check your state during signup before planning around PeterMD.
• −Not BBB accredited, and some documented complaints cite delayed medication fulfillment. Order refills ahead of your last dose rather than at the last minute.
• −PeterMD began as a testosterone replacement therapy platform; GLP-1 is an expansion, not the original core. The included video consultations give you a direct read on the clinical team.

Pros

• +FDA-approved brand paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199; with the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
• +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
• +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance

Cons

• −Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
• −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
• −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care

Pros

• +Compounded tirzepatide is $149/mo microdose or $179/mo full-dose on the yearly plan; 3-month pricing is $169/mo microdose or $219/mo full-dose
• +Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android, first-party in-treatment logging is uncommon among compounded-only platforms
• +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack

Cons

• −Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded tirzepatide.
• −Tirzepatide-only on the compounded side, compounded semaglutide is NOT offered, a narrower medication menu than peers like Maximus, Ro, or Henry Meds
• −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill

Pros

• +Competitive entry pricing: $179/mo for compounded semaglutide and $209/mo for compounded tirzepatide undercuts the mid-tier compounded average (~$199/$299) for both formats
• +Named medical advisor with disclosed credentials, Dr. Mark Rosenberg, M.D., board-certified, 25+ years anti-aging and metabolic-health experience. Most compounded-only platforms in this price tier name no medical director.
• +Multi-month bundles (1, 3, 6, 12 months) with cancel-anytime, no-monthly-membership flexibility, strong fit for users who want to lock in a price without subscription lock-in

Cons

• −Compounded-only, no brand-name FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or oral GLP-1 (Foundayo). Patients who want an FDA-approved finished product need a different provider for that piece.
• −Pharmacy partner not publicly named, disclosures reference "licensed U.S. pharmacies" generically. If verifying 503A licensing or USP-797 accreditation upfront matters to you, use the option to specify a licensed pharmacy of your choice on intake.
• −Operating entity is Dynamo Group LLC under a brand license, NOT Bodybuilding.com directly. The "Trusted by millions since 1999" framing describes the parent retail brand; the GLP-1 program launched in 2026 and stands on its own record.

Pros

• +No membership fee, pay only for treatments you choose, unlike platforms that require $50-149/mo subscriptions
• +GLP-1 microdosing protocols available from $79/mo, one of only two platforms offering sub-therapeutic doses for metabolic health
• +Broader longevity medicine platform with NAD+, metformin, and rapamycin alongside GLP-1 treatment

Cons

• −$50/mo clinical oversight fee is charged on top of medication; the published $199 semaglutide path totals $249/mo
• −Longevity medicine framing may overwhelm patients who just want straightforward weight loss medication
• −Cold-shipping limitations may affect availability in Alaska and Hawaii

Pros

• +Specializes in oral compounded semaglutide, the go-to for patients who absolutely won't do injections
• +Needle-free oral semaglutide tablets from $99/mo, one of the lowest oral entry prices in the table, with oral tirzepatide ($199/mo) and auto-refill injectables ($149 to $199/mo) if you switch formats
• +Clear educational content about oral semaglutide absorption and how to maximize effectiveness

Cons

• −Compounded only, no brand-name Wegovy or Zepbound. Strut does not publish formulation-specific pharmacokinetic or comparative outcome evidence for its oral tablets, so their absorption and weight-loss results versus approved injections are unknown.
• −Compounded oral semaglutide is not FDA-approved as a finished product or established as bioequivalent to approved oral or injectable semaglutide; do not infer equivalent dosing or results

Pros

• +Published average weight loss outcomes: 12-15% body weight at 6 months across their patient base
• +Dedicated care coordinator assigned to each patient, not a rotating pool of providers
• +Transparent pricing: $250/mo covers medication, shipping, and all consultations

Cons

• −$250/mo all-in sits in the upper-mid range, $90 more than Willow for a similar model; the premium pays for the dedicated coordinator and published outcomes
• −No insurance accepted, and no superbill provided for FSA/HSA reimbursement

Pros

• +One of the few compounded providers offering both oral tablets and injectable semaglutide
• +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
• +Sleek onboarding experience with clear progress tracking through their patient portal

Cons

• −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
• −Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
• −The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148

Pros

• +Offers both compounded semaglutide and a compounded GLP-1 + GIP option through one intake
• +The landing advertises a $179 entry floor, although that figure does not match the medication schedule in the official terms
• +Onboarding takes under 15 minutes with same-day provider review for most applications

Cons

• −The advertised $179 floor conflicts with TrimRx's own terms: semaglutide is listed at $199 for the first order and $299 for follow-ups; GLP-1 + GIP is $349 first and $399 follow-up. Treat the total as unresolved until checkout
• −Trustpilot is 3.6/5 across 5,485 reviews with 32% one-star; BBB rates TrimRx F/not accredited with 728 unanswered and 221 unresolved complaints
• −The same paid-but-no-medication, billing, refund and fulfillment themes recur across BBB and Trustpilot, meeting our rubric's cross-platform -3.0 fulfillment-failure threshold

Pros

• +Five medication formats, the broadest compounded-GLP-1 menu in DTC telehealth, including the rare oral tirzepatide tablet that almost no competitor offers
• +$199/mo entry price for both injectable and sublingual semaglutide is competitive in the mid-tier compounded segment
• +Fast onboarding: 5-10 minute online questionnaire, physician review in 24-48 hours, medication delivered in 3-7 business days with temperature-controlled shipping

Cons

• −No brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro), so patients who want or need an FDA-approved finished product should buy elsewhere
• −Light public disclosure: founders, executive team, medical director, and specific compounding-pharmacy partners are not named on the public site, ask support before enrolling if provenance matters to you
• −Cash-pay only, does not bill commercial insurance, Medicare, or Medicaid. HSA/FSA payments are accepted, which is the main way to soften the cost.

Pros

• +$99/mo compounded semaglutide on the 12-month plan, with a $133/mo 3-month option
• +Flat pricing across doses, clinician review, dose adjustments, and overnight shipping included
• +Licensed clinicians in all 50 states through MD Integrations, with most files reviewed within about 24 hours

Cons

• −The dispensing 503A pharmacy is described by type while its name and license remain absent from the public site
• −Legal entity, headquarters, executive team, and medical director remain undisclosed
• −The tirzepatide product page advertises $149/mo while the current affiliate landing and FAQ say $179/mo, so confirm the checkout rate

Pros

• +Lowest published microdose medication price we track, $79.99/mo semaglutide; consultation and lab fees are separate
• +GLP-1 microdosing available for BMI as low as 22, the only platform serving patients below standard obesity criteria
• +Maximus markets a semaglutide formula with added glycine and B12 as a way to ease nausea; we found no Maximus-specific clinical trial validating that claim

Cons

• −The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
• −Compounding pharmacy partners are not disclosed, a transparency gap for a healthcare platform
• −Bulk-plan prices rise as your dose escalates; ask for the full dose-price schedule up front so total cost isn't a surprise

Pros

• +Flat pricing that does not increase as your dose is titrated, which is the opposite of how most compounded programs bill
• +A physician typically reviews the intake within four hours, and labs can be ordered when clinically appropriate
• +24/7 unlimited messaging with the clinical team, published as a standing commitment rather than a business-hours window

Cons

• −'Cancel anytime, no penalties' on the product pages is contradicted by the terms. Cancel a multi-month plan early and the months you already used are re-rated to the shortest plan that covers them, and you are billed the difference as a one-time charge. Their own worked example: leave a 12-month plan after three months and you are re-rated to the 3-month price
• −The plan pricing that used to be fully public is now behind intake. The page shows 'as low as $99' against a struck-through $299, says your price depends on plan length, and exposes no plan selector. The month-to-month rate is not published anywhere
• −The August 1 terms say consultations and ordered labs may be separately payable. Those charges may remain due even when a clinician decides you are not eligible for a prescription, so the medication floor is not an all-in quote

Pros

• +$99/mo compounded semaglutide on the annual plan (billed $1,188 once yearly) is among the cheapest flat recurring rates we track; tirzepatide annual is $125/mo ($1,500 yearly)
• +Flat pricing across all doses, your monthly price does not rise as your dose titrates up
• +Consult and overnight shipping included in the plan price, no add-on fees; HSA/FSA accepted, Klarna and Affirm financing available

Cons

• −Trustpilot FELL from 4.6 earlier in 2026 to 3.4 across 71 reviews, ranking #62 of 70 in its category, recurring complaints cite account closures and withheld refunds
• −Once a prescription is signed, payments are final, no pro-rating, cancelling an annual plan mid-year forfeits the remainder. Full refund is available only BEFORE the prescription is signed
• −No legal entity disclosed, the site identifies only 'Trimi Health' with no LLC/Inc suffix and no street address (New York appears only in the site's schema markup)

Pros

• +The lowest advertised compounded-semaglutide medication floor on this site at $69/mo, if the promotional rate holds; the consultation fee and all-in total remain unresolved
• +Names its partner pharmacy publicly with a link (RedRock Pharmacy), which most competitors do not do
• +Free 1-2 day shipping with a stated one-day turnaround from intake to a written prescription

Cons

• −No independent review record at all. The Trustpilot profile is claimed and shows zero reviews, so the '125k+ Happy Customers' homepage claim cannot be verified anywhere
• −The $69 price sits under a countdown timer that is a standing feature of the page rather than a dated deadline, next to a 'locked-in for life' claim. The regular price is $299
• −'Cancel Anytime' appears three times on the homepage, but the terms say cancellation deadlines 'will be disclosed at checkout or in your account'. A deadline you only see after committing is not cancel-anytime